Compared with the CRP low-risk group, participants in the hs-CRP high-risk group had a 36.4% higher risk of hypertension after adjustment for all covariates (hazard ratio: 1.364, 95% CI: 1.006–1.849; p = 0.03). This evidence concerns the gene CRP and hypertensive disorder.